Clinical Trial Update: Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD) [Phase 2, Phase 3]

View source ↗

Summary

Airway Therapeutics is conducting Phase 2 and Phase 3 trials to assess the efficacy and safety of Zelpultide Alfa in preterm neonates at high risk for bronchopu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Zelpultide Alfa (Zelpultide alfa)

Snippet

Sponsor: Airway Therapeutics, Inc. | Conditions: Bronchopulmonary Dysplasia | Phase 2, Phase 3 | Status: RECRUITING